• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nasal T cell lymphoma: a rare entity.

作者信息

Kazi Maliha, Ikram Mubasher, Junaid Montasir

机构信息

Department of Otolaryngology, Head and Neck Surgery, The Aga Khan University Hospital, Karachi.

Department of ENT- Head and Neck Surgery, Jinnah Medical and Dental College, Karachi.

出版信息

J Coll Physicians Surg Pak. 2014 Mar;24 Suppl 1:S50-1.

PMID:24718007
Abstract

Nasal type of Natural Killer (NK)/T cell lymphoma manifests in the nasal cavity. Approximately 95% of them are associated with EBV(Ebstein Barr Virus) with a strong predilection for the Asian population. It has certain systemic and localized symptoms which aid in diagnosis of the condition. However, the histological criteria is pivotal in confirming the diagnosis as well as aiding in confirming the association of EBV. Nasal type of NK/T cell lymphoma has a guarded prognosis. Treatment plan include radiotherapy with concurrent chemotherapy. Despite all this, the 5-year survival rate ranges from 15-75%. A 35 years old male presented with an ulcerative nasal lesion. Diagnosed as nasal type of NK/T cell lymphoma via a tissue biopsy, it was managed by chemo-radiotherapy leading to complete resolution of symptoms and disease free on his follow-up 6 months later.

摘要

相似文献

1
Nasal T cell lymphoma: a rare entity.
J Coll Physicians Surg Pak. 2014 Mar;24 Suppl 1:S50-1.
2
Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.智利的鼻型自然杀伤/T细胞淋巴瘤及其与I型/XhoI缺失株爱泼斯坦-巴尔病毒的关联。
J Clin Pathol. 2007 Jun;60(6):656-60. doi: 10.1136/jcp.2005.034199. Epub 2006 Jun 14.
3
[Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].[鼻腔原发性非霍奇金淋巴瘤患者的治疗选择与结局]
Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):58-61.
4
Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.上呼吸道和消化道 NK/T 细胞淋巴瘤鼻型与非鼻型之间的免疫表型和临床差异。
Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):806-13. doi: 10.1016/j.ijrobp.2013.12.005. Epub 2014 Feb 1.
5
[Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].鼻型NK/T细胞非霍奇金淋巴瘤患者的预后分析——附93例报告
Ai Zheng. 2005 Dec;24(12):1493-7.
6
Fine needle aspiration cytology of CD56-positive natural killer/T-cell lymphoma of soft tissue.软组织CD56阳性自然杀伤/T细胞淋巴瘤的细针穿刺细胞学检查
Cancer. 2002 Dec 25;96(6):344-50. doi: 10.1002/cncr.10885.
7
[Nasal NK cell lymphoma with hemophagocytic syndrome developed tumor lysis syndrome after CHOP therapy].
Rinsho Ketsueki. 2002 Nov;43(11):988-92.
8
[Prognostic analysis of 62 cases of nasal NK/T-cell lymphoma].62例鼻型NK/T细胞淋巴瘤的预后分析
Ai Zheng. 2006 Sep;25(9):1173-7.
9
Novel treatment for early-stage nasal natural killer/T-cell lymphoma: intra-maxillary arterial infusion chemotherapy with concomitant radiotherapy.早期鼻腔自然杀伤/T细胞淋巴瘤的新型治疗方法:上颌动脉灌注化疗联合放疗
Hematol Oncol. 2017 Jun;35(2):158-162. doi: 10.1002/hon.2273. Epub 2015 Nov 13.
10
[Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].[中线鼻及鼻型NK/T细胞淋巴瘤的临床特征与治疗]
Zhonghua Yi Xue Za Zhi. 2001 Jul 10;81(13):773-5.